Skip to content
Biopharma Boehringer Ingelheim took a big step toward achieving the company’s goal of carbon neutrality by 2030 with the July 8 inauguration of a […]
Boehringer Ingelheim biomass plant cuts drug maker’s carbon footprint Read More »
From oncology to AI to burgeoning biotech hubs worldwide, the 2024 BIO International Convention brought together the global biotech community to discuss key trends
BIO 2024: 5 takeaways about the biotech business ecosystem Read More »
In August 2020, the World Health Organization (WHO) adopted a global strategy to eliminate cervical cancer in our lifetime. “To eliminate cervical cancer,” according
We can eliminate cervical cancer in our lifetime – here’s how Read More »
France’s government is putting €54 billion toward the growth of priority industries, including the biotech sector, learned a high-level delegation to Paris organized by
BIO’s Paris delegation strengthens Franco-American biotech ties Read More »
A recent study conducted by the Office of Health Economics (OHE, the world’s oldest independent health economics research organization), and funded by the International
Social value of vaccines far exceeds their cost, new study finds Read More »
A year ago, the sentiment for the industry was extremely low. In 2023, the biotech stock indices were sliding to potential new lows, levels
5 reasons for investor optimism at BIO-Europe Spring 2024 Read More »
Antimicrobial resistance (AMR) is a health concern with growing global significance. AMR, which is developed resistance to antimicrobial treatments in bacteria, fungi, parasites, and
BIO Ventures for Global Health combats AMR through R&D in Africa Read More »
The World Trade Organization (WTO) 13th Ministerial concluded on Friday, March 1, without an agreement to expand the COVID-19 intellectual property waiver to therapeutics
WTO Ministerial ends, no expansion of COVID IP waiver Read More »
As the 13th Ministerial Conference of the World Trade Organization (WTO) kicks off (Feb. 26-29), the expansion of the COVID-19 IP waiver remains a
Why the WTO should focus on addressing trade-related aspects of pandemic preparedness Read More »
A proposed World Trade Organization (WTO) IP waiver could have scuttled investment in biotech’s new diabetes drug and already impacts the firm’s decisions about
BIO Board member tells Congress WTO IP waivers hurt innovation Read More »
